BEST UNLIMITED TURBO SHORT CERTIFICATE - ELI LILLY & CO | Real-time Euronext Paris 11:01:07 2024-06-20 EDT | ||
| 1.66 EUR | -5.95% |
|
| Current month | -43.61% | ||
| 1 month | -55.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-20 | 1.66 | -5.95% |
| 24-06-19 | 1.765 | -4.08% |
| 24-06-18 | 1.84 | -0.54% |
| 24-06-17 | 1.85 | -5.61% |
| 24-06-14 | 1.96 | -7.55% |
Real-time Euronext Paris
Last update June 20, 2024 at 11:01 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| 1B77S | |
| ISIN | DE000SU9EXN1 |
| Date issued | 2024-02-15 |
| Strike | 981.4 $ |
| Maturity | Unlimited |
| Parity | 50 : 1 |
| Emission price | 4.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.98 € |
|---|---|
| Lowest since issue | 1.56 € |
| Spread | 0.02 € |
| Spread % | 1.20% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
891.5
USD
Average target price
855.4
USD
Spread / Average Target
-4.05%
- Stock Market
- Certificates
- 1B77S Certificat
